• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用临床高风险同种异体移植物解决器官短缺问题的经济影响。

The economic impact of addressing the organ shortage with clinically high-risk allografts.

作者信息

Lentine Krista L, Schnitzler Mark A

机构信息

Department of Internal Medicine, Saint Louis University Center for Outcomes Research, USA.

出版信息

Mo Med. 2011 Jul-Aug;108(4):275-9.

PMID:21905445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6188414/
Abstract

Expanding gaps between the number of patients awaiting transplantation and the number who receive organs in the United States has been associated with heightened disease severity among transplant candidates and more common use of organs from non-standard donors. We summarize data on the economic consequences of liver and renal allograft quality in contemporary practice. Policy makers and providers must work together to ensure that financial disincentives do not lead to wastage of lifesaving organs.

摘要

在美国,等待移植的患者数量与接受器官移植的患者数量之间的差距不断扩大,这与移植候选者中疾病严重程度的加剧以及非标准供体器官使用的增多有关。我们总结了当代实践中肝和肾同种异体移植质量的经济后果数据。政策制定者和医疗服务提供者必须共同努力,确保经济上的不利因素不会导致挽救生命的器官被浪费。

相似文献

1
The economic impact of addressing the organ shortage with clinically high-risk allografts.使用临床高风险同种异体移植物解决器官短缺问题的经济影响。
Mo Med. 2011 Jul-Aug;108(4):275-9.
2
Introducing incentives in the market for live and cadaveric organ donations.在活体和尸体器官捐赠市场引入激励措施。
J Econ Perspect. 2007 Summer;21(3):3-24. doi: 10.1257/jep.21.3.3.
3
Opportunities and challenges of expanded criteria organs in liver and kidney transplantation as a response to organ shortage.扩大标准器官用于肝肾移植应对器官短缺的机遇与挑战
Mo Med. 2011 Jul-Aug;108(4):269-74.
4
Current Status of Simultaneous Liver-Kidney Transplantation in the United States.美国的肝肾联合移植现状。
Liver Transpl. 2019 May;25(5):797-806. doi: 10.1002/lt.25444. Epub 2019 Apr 3.
5
Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.接受或拒绝已故供体肾移植与肾移植候选人结局的关系。
JAMA Netw Open. 2019 Aug 2;2(8):e1910312. doi: 10.1001/jamanetworkopen.2019.10312.
6
The UNOS OPTN Waiting List and Donor Registry: 1988-1996.器官共享联合网络(UNOS)等待名单与捐赠者登记处:1988 - 1996年
Clin Transpl. 1996:69-90.
7
Can we mitigate the effects of simultaneous liver-kidney transplantation through increased utilization of HCV-positive donors?我们能否通过增加对丙型肝炎病毒(HCV)阳性供体的利用来减轻肝肾联合移植的影响?
Am J Transplant. 2018 Oct;18(10):2604-2605. doi: 10.1111/ajt.15076. Epub 2018 Sep 5.
8
The bioethics and utility of selling kidneys for renal transplantation.肾脏移植中售卖肾脏的生物伦理学及实用性。
Transplant Proc. 2008 Jun;40(5):1264-70. doi: 10.1016/j.transproceed.2008.03.095.
9
United Network for Organ Sharing Donor Data Update, 1988-1995.器官共享联合网络捐赠者数据更新,1988 - 1995年。
Transplant Proc. 1997 Feb-Mar;29(1-2):122-4. doi: 10.1016/s0041-1345(96)00030-9.
10
The donor supply.供体供应。
Transplant Proc. 1997 Dec;29(8):3299-3300. doi: 10.1016/s0041-1345(97)00918-4.

引用本文的文献

1
Impact of Social Media on Self-Referral Patterns for Living Kidney Donation.社交媒体对活体肾脏捐献自我推荐模式的影响。
Kidney360. 2020 Oct 30;1(12):1419-1425. doi: 10.34067/KID.0003212020. eCollection 2020 Dec 31.
2
The ECM: To Scaffold, or Not to Scaffold, That Is the Question.细胞外基质:构建还是不构建,这是个问题。
Int J Mol Sci. 2021 Nov 24;22(23):12690. doi: 10.3390/ijms222312690.
3
Increasing the pool of deceased donor organs for kidney transplantation.增加用于肾移植的已故供体器官库。
Nat Rev Nephrol. 2012 Mar 27;8(6):325-31. doi: 10.1038/nrneph.2012.60.

本文引用的文献

1
The economic implications of broader sharing of liver allografts.更广泛地共享肝脏供体的经济影响。
Am J Transplant. 2011 Apr;11(4):798-807. doi: 10.1111/j.1600-6143.2011.03443.x. Epub 2011 Mar 14.
2
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.供体特征、肝病严重程度和肝移植成本之间的相互作用。
Liver Transpl. 2011 Mar;17(3):233-42. doi: 10.1002/lt.22230.
3
Liver transplantation cost in the model for end-stage liver disease era: looking beyond the transplant admission.终末期肝病时代模型中的肝移植成本:超越移植入院的考量
Liver Transpl. 2009 Oct;15(10):1270-7. doi: 10.1002/lt.21802.
4
Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.潜在肾移植候选人的心血管风险评估:方法与争议。
Am J Kidney Dis. 2010 Jan;55(1):152-67. doi: 10.1053/j.ajkd.2009.06.032. Epub 2009 Sep 23.
5
Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors.扩大标准供体肾移植中脉动式机器灌注成本降低的关联
Am J Transplant. 2008 Nov;8(11):2391-401. doi: 10.1111/j.1600-6143.2008.02412.x.
6
Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion.扩大标准供肾丢弃的决定因素:活检和机器灌注的影响
Am J Transplant. 2008 Apr;8(4):783-92. doi: 10.1111/j.1600-6143.2008.02157.x. Epub 2008 Feb 19.
7
The effects of donor and recipient practices on transplant center finances.供体和受体操作对移植中心财务状况的影响。
Am J Transplant. 2008 Mar;8(3):586-92. doi: 10.1111/j.1600-6143.2007.02098.x.
8
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality.已故供体肝移植的生存获益与候选者疾病严重程度及供体质量的关系。
Am J Transplant. 2008 Feb;8(2):419-25. doi: 10.1111/j.1600-6143.2007.02086.x. Epub 2008 Jan 7.
9
Who pays for biliary complications following liver transplant? A business case for quality improvement.肝移植术后胆道并发症的费用由谁承担?质量改进的商业案例。
Am J Transplant. 2006 Dec;6(12):2978-82. doi: 10.1111/j.1600-6143.2006.01575.x.
10
Geographic differences in event rates by model for end-stage liver disease score.终末期肝病模型评分的事件发生率的地域差异。
Am J Transplant. 2006 Oct;6(10):2470-5. doi: 10.1111/j.1600-6143.2006.01508.x.